LMG Life Sciences Awards North America 2021: shortlist revealed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards North America 2021: shortlist revealed

life-sciences-awards-2021-americas-for-dat.jpg

The LMG Life Sciences Awards is excited to present its shortlist for the 2021 North America Awards

The LMG Life Sciences Awards has released the full list of finalists for its 2021 North America awards.

The awards recognise the leading achievements and attorneys in life sciences law in the whole of the Americas.

Winners will be announced on September 22 2021.

A preview of the finalists can be found below, but the full list is available on the awards website.

The LMG Life Sciences research team carefully selected each finalist after a thorough research period which included an analysis of direct submissions, followed by interviews with law firms and in-house teams, client feedback, and much deliberation.

All of the work accepted for shortlisting closed during the research period, January 1 to December 31 2020.The awards do not recognise cases, deals, or transactions completed outside of this window.

If you have any questions regarding our research process, please contact our editor, Chris Adams: chris.adams@euromoneyny.com

The LMG Life Sciences Awards will be announcing the winners on September 22 at our awards ceremony.To find out more – and to find out how you can promote your success – please contact George Reeves: george.reeves@euromoneyny.com

 

Preview of the LMG Life Sciences Awards Americas 2021 shortlist:

Appellate Litigator of the Year – Intellectual Property

Deanne Maynard – Morrison & Foerster

Edward Reines – Weil Gotshal & Manges

Marky Perry – Gibson Dunn & Crutcher

Matthew Wolf – Arnold & Porter

Steffen Johnson – Wilson Sonsini Goodrich & Rosati

Hatch-Waxman Litigator of the Year – Branded

Adam Perlman – Latham & Watkins

Christopher Sipes – Covington & Burling

David Berl – Williams & Connolly

Jane Love – Gibson Dunn & Crutcher

Lisa Ferri – Mayer Brown

Lisa Pensabene – O’Melveny Myers

 

US Rising Star – Intellectual Property

Assad Rajani – Arnold & Porter

Heather Petruzzi – WilmerHale

Jennifer Nock – Rothwell Figg Ernst & Manbeck

Patrick Morris – Perkins Coie

Vanessa Yen – King & Spalding

 

Canadian Patent Litigator of the Year

Dominique Hussey – Bennett Jones

Harry Radomski – Goodmans

Kristin Wall – Norton Rose Fulbright

Peter Wilcox – Belmore Neidrauer

Sheldon Hamilton – Smart & Biggar

Steven Mason – McCarthy Tétrault

 

View the full 2021 shortlist.

more from across site and SHARED ros bottom lb

More from across our site

The US decision marks a rare grant of a request under the Uniform Fraudulent Transfer Act in a patent case
Stobbs has applied to strike out a contempt of court application filed against the firm and two of its lawyers
With trademark volumes surging, trademark teams need to think beyond traditional clearance searches, towards a continuous, intelligence-led workflow, says Meghan Medeiros of Corsearch
Brazilian in-house counsel say law firms’ technology investments have not translated into tangible benefits, meaning tech use is a minor factor when selecting advisers
A lack of comfort among some salaried partners shows why law firms must actively foster inclusion, not merely focus on diversity mandates
Arrival of Laura Alonso, alongside a team of 11, will bring ‘significant value’ to ECIJA clients, says CEO
In the first of a two-part article, lawyers at Spruson & Ferguson and Marshall Gerstein provide an overview of China’s system for appealing against patent invalidation decisions
Lawyers and corporate leaders at INTA’s Business of M&A conference in New York discussed how cross-practice collaboration and early in-house involvement can help deals
Lily Li, partner at Morrison Foerster, shares how her litigation team helped secure victory at the ITC in a patent infringement case
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
Gift this article